President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps ...
MET-3 is under clinical development by Nubiyota and currently in Phase II for Hypertriglyceridemia. According to GlobalData, Phase II drugs for Hypertriglyceridemia have a 52% phase transition success ...
KLS-1 is under clinical development by Vector Vitale and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II drugs for Metastatic Melanoma have a 36% phase transition ...
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.
Even before Trump enters the White House, the planet is showing worrying vital signs with scientists virtually certain 2024 ...